BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17501969)

  • 21. Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin.
    Bettoli V; Zauli S; Borghi A; Toni G; Ricci M; Bertoldi AM; Virgili A
    G Ital Dermatol Venereol; 2017 Feb; 152(1):13-17. PubMed ID: 26889724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sacroiliitis secondary to isotretinoin.
    Levinson M; Gibson A; Stephenson G
    Australas J Dermatol; 2012 Nov; 53(4):298-300. PubMed ID: 23157782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Night blindness following low-dose isotretinoin.
    Halpagi P; Grigg J; Klistorner A; Damian DL
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
    [No Abstract]   [Full Text] [Related]  

  • 24. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
    Hasibur MR; Meraj Z
    Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systemic retinoid therapy in severe acne infantum].
    Hütten M; Baron JM; Ott H
    Hautarzt; 2008 Jun; 59(6):454-7. PubMed ID: 18470501
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
    Rigopoulos D; Larios G; Katsambas AD
    Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged thrombocytopenia associated with isotretinoin.
    Moeller KE; Touma SC
    Ann Pharmacother; 2003 Nov; 37(11):1622-4. PubMed ID: 14565796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermabrasion for acne scars during treatment with oral isotretinoin.
    Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
    Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
    Kaymak Y; Ilter N
    Dermatol Nurs; 2006 Dec; 18(6):576-80. PubMed ID: 17286159
    [No Abstract]   [Full Text] [Related]  

  • 35. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L; Oraichi D; Bérard A
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
    DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
    J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.